Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Prepaid Assets (2019 - 2025)

Avidity Biosciences (RNA) has disclosed Prepaid Assets for 7 consecutive years, with $67.4 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Prepaid Assets rose 126.57% year-over-year to $67.4 million, compared with a TTM value of $67.4 million through Jun 2025, up 126.57%, and an annual FY2024 reading of $18.8 million, changed N/A over the prior year.
  • Prepaid Assets was $67.4 million for Q2 2025 at Avidity Biosciences, up from $18.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $67.4 million in Q2 2025 and bottomed at $4.0 million in Q1 2021.
  • Average Prepaid Assets over 5 years is $15.5 million, with a median of $8.9 million recorded in 2021.
  • The sharpest move saw Prepaid Assets soared 472.65% in 2021, then fell 23.16% in 2022.
  • Year by year, Prepaid Assets stood at $5.6 million in 2021, then skyrocketed by 118.2% to $12.2 million in 2022, then increased by 5.64% to $12.9 million in 2023, then skyrocketed by 45.5% to $18.8 million in 2024, then soared by 259.07% to $67.4 million in 2025.
  • Business Quant data shows Prepaid Assets for RNA at $67.4 million in Q2 2025, $18.8 million in Q4 2024, and $29.8 million in Q2 2024.